HomeCompareMARK vs CHD

MARK vs CHD: Dividend Comparison 2026

MARK yields 133333.33% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MARK wins by $8.549287649225948e+27M in total portfolio value
10 years
MARK
MARK
● Live price
133333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.549287649225948e+27M
Annual income
$8,536,692,923,921,903,000,000,000,000,000,000.00
Full MARK calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — MARK vs CHD

📍 MARK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMARKCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MARK + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MARK pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MARK
Annual income on $10K today (after 15% tax)
$11,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$7,256,188,985,333,618,000,000,000,000,000,000.00/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, MARK beats the other by $7,256,188,985,333,618,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MARK + CHD for your $10,000?

MARK: 50%CHD: 50%
100% CHD50/50100% MARK
Portfolio after 10yr
$4.274643824612974e+27M
Annual income
$4,268,346,461,960,951,400,000,000,000,000,000.00/yr
Blended yield
99.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

MARK
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-305.6
Piotroski
3/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MARK buys
0
CHD buys
0
No recent congressional trades found for MARK or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMARKCHD
Forward yield133333.33%1.27%
Annual dividend / share$2.00$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%23.1%
Portfolio after 10y$8.549287649225948e+27M$26.4K
Annual income after 10y$8,536,692,923,921,903,000,000,000,000,000,000.00$1,292.51
Total dividends collected$8.548462633639563e+27M$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: MARK vs CHD ($10,000, DRIP)

YearMARK PortfolioMARK Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$13,344,033$13,333,333.33$10,856$156.32+$13.33MMARK
2$16,642,357,036$16,628,078,920.04$11,811$195.24+$16642.35MMARK
3$19,399,246,208,345$19,381,438,886,316.95$12,883$244.38+$19399246.20MMARK
4$21,134,841,850,983,004$21,114,084,657,540,070.00$14,091$306.64+$21134841850.97MMARK
5$21,520,840,488,109,330,000$21,498,226,207,328,780,000.00$15,463$385.88+$21520840488109.31MMARK
6$20,481,776,417,848,300,000,000$20,458,749,118,526,020,000,000.00$17,033$487.17+$20481776417848300.00MMARK
7$18,219,078,762,075,947,000,000,000$18,197,163,261,308,848,000,000,000.00$18,843$617.36+$18219078762075947008.00MMARK
8$15,147,396,542,885,863,000,000,000,000$15,127,902,128,610,440,000,000,000,000.00$20,947$785.72+$1.5147396542885863e+22MMARK
9$11,770,771,312,189,630,000,000,000,000,000$11,754,563,597,888,743,000,000,000,000,000.00$23,419$1,004.91+$1.1770771312189631e+25MMARK
10$8,549,287,649,225,948,000,000,000,000,000,000$8,536,692,923,921,903,000,000,000,000,000,000.00$26,350$1,292.51+$8.549287649225948e+27MMARK

MARK vs CHD: Complete Analysis 2026

MARKStock

Remark Holdings, Inc. primarily focuses on the development and deployment of artificial intelligence-based solutions for businesses and software developers. It operates a data and AI software platform under the Remark AI name in the United States and the KanKan AI name in the Asia Pacific region that offers AI-based computer vision products, computing devices, and software-as-a-service solutions for the retail, urban life cycle, workplace and food safety, railway safety, and biosafety industries. The company also provides Thermal kits, which includes a thermal imaging camera, calibrating device, computer to monitor the video feed, supporting equipment, and AI software to scan crowds and areas of high foot traffic for indications that certain persons with elevated temperatures may require secondary screening; and rPad thermal imaging devices, a single-post stand to scan individuals on a one-by-one basis for authorized entry. In addition, it owns and operates Sharecare, a web-based platform that facilitates search for health and wellness information; and Bikini.com, an e-commerce website that sells swimwear and accessories in the latest styles, as well as offers advertising services. The company was formerly known as Remark Media, Inc. and changed its name to Remark Holdings, Inc. in April 2017. Remark Holdings, Inc. was incorporated in 2006 and is headquartered in Las Vegas, Nevada.

Full MARK Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this MARK vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MARK vs SCHDMARK vs JEPIMARK vs OMARK vs KOMARK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.